Study title: A short notice and intermediateterm control of success after triennial hypersensitation with Graminea Pollen-Depot- Allergoid (Allergovit); Age of patients: 6-67 Years
Type of medicine: Allergen extracts | |||||
Therapeutic area: Immune System Diseases | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: Grasses | |||||
ATC code: V01AA02 , V01AA05 , V01AA20 | |||||
Document link: | |||||
Document date: | |||||
Study number: Post-Marketing study Nr. 95 | |||||
EudraCT number: | |||||
Scope of study: | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |